Dataset Information


Aortic Stenosis and Transcatheter Aortic Valve Implantation: Current Status and Future Directions in Korea.

ABSTRACT: Transcatheter aortic valve implantation (TAVI) has been accepted as one of primary options for treatment of symptomatic severe aortic stenosis. Although TAVI has been predominantly used for patients at high risk or with old age who were not considered optimal candidates for surgical aortic valve replacement (SAVR), its indication is now expanding toward low risk profile and younger age. Many clinical trials are now ongoing to test the possibility of TAVI for use in patients even with uncharted indications who are not eligible for SAVR in current guidelines but may benefit from valve replacement. Current issues including periprocedural safety, long-term adverse events, hemodynamics and durability associated with TAVI should be also solved for expanding use of TAVI. The review presents current status and future directions of TAVI and discusses perspectives in Korea.


PROVIDER: S-EPMC6428950 | BioStudies | 2019-01-01


REPOSITORIES: biostudies

Similar Datasets

2019-01-01 | S-EPMC6660647 | BioStudies
1000-01-01 | S-EPMC5639221 | BioStudies
2018-01-01 | S-EPMC5958417 | BioStudies
2020-01-01 | S-EPMC7501921 | BioStudies
1000-01-01 | S-EPMC6362570 | BioStudies
2020-01-01 | S-EPMC7299574 | BioStudies
1000-01-01 | S-EPMC5040923 | BioStudies
2015-01-01 | S-EPMC4658107 | BioStudies
2020-01-01 | S-EPMC7286321 | BioStudies
2019-01-01 | S-EPMC6759164 | BioStudies